These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38398377)

  • 1. Management and Outcome of Women with Placenta Accreta Spectrum and Treatment with Uterine Artery Embolization.
    Neef V; Flinspach AN; Eichler K; Woebbecke TR; Noone S; Kloka JA; Jennewein L; Louwen F; Zacharowski K; Raimann FJ
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and outcomes of a uterine artery embolization and tranexamic acid protocol for placenta accreta spectrum.
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Am J Obstet Gynecol; 2023 Jul; 229(1):61.e1-61.e7. PubMed ID: 36965865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine artery embolization for postpartum hemorrhage with placenta accreta spectrum.
    Jeon GU; Jeon GS; Kim YR; Ahn EH; Jung SH
    Acta Radiol; 2023 Jul; 64(7):2321-2326. PubMed ID: 37093745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cesarean delivery with and without uterine artery embolization for the management of placenta accreta spectrum disorder-A comparative study.
    Mohr-Sasson A; Hochman R; Anteby M; Spira M; Castel E; Hendler I; Mazaki-Tovi S; Sivan E
    Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1374-1380. PubMed ID: 32282925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine Artery Embolization following Cesarean Delivery but prior to Hysterectomy in the Management of Patients with Invasive Placenta.
    Wang M; Ballah D; Wade A; Taylor AG; Rizzuto G; Li B; Lucero J; Chen LM; Kohi MP
    J Vasc Interv Radiol; 2019 May; 30(5):687-691. PubMed ID: 30922797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 7. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.
    Melber DJ; Berman ZT; Jacobs MB; Picel AC; Conturie CL; Zhang-Rutledge K; Binder PS; Eskander RN; Roberts AC; McHale MT; Ramos GA; Ballas J; Kelly TF
    Am J Obstet Gynecol; 2021 Oct; 225(4):442.e1-442.e10. PubMed ID: 34245679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta.
    Pan Y; Zhou X; Yang Z; Cui S; De W; Sun L
    Int J Gynaecol Obstet; 2017 Apr; 137(1):45-50. PubMed ID: 28098341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planned caesarean in the interventional radiology cath lab to enable immediate uterine artery embolization for the conservative treatment of placenta accreta.
    Bouvier A; Sentilhes L; Thouveny F; Bouet PE; Gillard P; Willoteaux S; Aubé C
    Clin Radiol; 2012 Nov; 67(11):1089-94. PubMed ID: 22622352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected uterine body placenta accreta spectrum with placenta previa in a subsequent pregnancy after uterine artery embolization: a case report.
    Sugai S; Yamawaki K; Haino K; Nishijima K
    BMC Pregnancy Childbirth; 2022 Sep; 22(1):706. PubMed ID: 36100926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic uterine artery embolization during cesarean delivery for placenta previa complicated by placenta accreta.
    Yuan Q; Jin Y; Chen L; Ling L; Bai XM
    Int J Gynaecol Obstet; 2020 Apr; 149(1):43-47. PubMed ID: 31778209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of prophylactic balloon occlusion of the internal iliac artery for the treatment of placenta accreta spectrum with placenta previa: a retrospective case-control study.
    Peng Y; Jiang L; Peng C; Wu D; Chen L
    BMC Pregnancy Childbirth; 2020 Jun; 20(1):349. PubMed ID: 32513127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Gynecol Oncol; 2022 Sep; 166(3):460-464. PubMed ID: 35781164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative Management of Invasive Placenta Using Combined Prophylactic Internal Iliac Artery Balloon Occlusion and Immediate Postoperative Uterine Artery Embolization.
    D'Souza DL; Kingdom JC; Amsalem H; Beecroft JR; Windrim RC; Kachura JR
    Can Assoc Radiol J; 2015 May; 66(2):179-84. PubMed ID: 25797171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study.
    El Gelany S; Mosbeh MH; Ibrahim EM; Mohammed M; Khalifa EM; Abdelhakium AK; Yousef AM; Hassan H; Goma K; Alghany AA; Mohammed HF; Azmy AM; Ali WA; Abdelraheim AR
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):313. PubMed ID: 31455286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine Artery Embolization for Management of Primary Postpartum Hemorrhage Associated with Placenta Accreta.
    Wang Z; Li X; Pan J; Zhang X; Shi H; Yang N; Jin Z
    Chin Med Sci J; 2016 Nov; 31(4):228-232. PubMed ID: 28065219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for postpartum haemorrhage in women with histologically verified placenta accreta spectrum disorders: a retrospective single-centre cross-sectional study.
    Ghaem Maghami N; Helfenstein F; Manegold-Brauer G; Amstad G
    BMC Pregnancy Childbirth; 2023 Nov; 23(1):786. PubMed ID: 37951863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.